10x Genomics EBITDA Margin 2018-2025 | TXG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for 10x Genomics (TXG) over the last 10 years. The current EBITDA margin for 10x Genomics as of March 31, 2025 is .
| 10x Genomics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.63B | $-0.13B | -20.96% |
| 2024-12-31 | $0.61B | $-0.15B | -24.71% |
| 2024-09-30 | $0.63B | $-0.16B | -24.60% |
| 2024-06-30 | $0.63B | $-0.21B | -32.75% |
| 2024-03-31 | $0.63B | $-0.23B | -36.26% |
| 2023-12-31 | $0.62B | $-0.22B | -35.54% |
| 2023-09-30 | $0.59B | $-0.19B | -32.49% |
| 2023-06-30 | $0.57B | $-0.14B | -24.82% |
| 2023-03-31 | $0.54B | $-0.15B | -27.05% |
| 2022-12-31 | $0.52B | $-0.14B | -26.36% |
| 2022-09-30 | $0.50B | $-0.13B | -25.79% |
| 2022-06-30 | $0.50B | $-0.11B | -21.49% |
| 2022-03-31 | $0.50B | $-0.06B | -11.02% |
| 2021-12-31 | $0.49B | $-0.03B | -5.09% |
| 2021-09-30 | $0.46B | $-0.42B | -91.50% |
| 2021-06-30 | $0.41B | $-0.47B | -116.01% |
| 2021-03-31 | $0.33B | $-0.50B | -151.05% |
| 2020-12-31 | $0.30B | $-0.52B | -172.24% |
| 2020-09-30 | $0.26B | $-0.12B | -44.27% |
| 2020-06-30 | $0.25B | $-0.06B | -25.10% |
| 2020-03-31 | $0.26B | $-0.04B | -14.02% |
| 2019-12-31 | $0.25B | $-0.02B | -9.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.282B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.172B | 59.16 |
| Hims & Hers Health (HIMS) | United States | $12.418B | 139.02 |
| Tempus AI (TEM) | United States | $12.340B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.592B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.751B | 59.77 |
| Privia Health (PRVA) | United States | $2.761B | 190.75 |
| Hinge Health (HNGE) | United States | $2.719B | 0.00 |
| Enovis (ENOV) | United States | $1.822B | 10.27 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Phreesia (PHR) | United States | $1.547B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.401B | 65.30 |
| Omnicell (OMCL) | United States | $1.370B | 24.15 |
| Fulgent Genetics (FLGT) | United States | $0.630B | 0.00 |
| Claritev (CTEV) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 140.50 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| Outset Medical (OM) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.347B | 778.33 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| Pulmonx (LUNG) | United States | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.095B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.44 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |